3D Medicines Inc. (HKG:1244)
Hong Kong · Delayed Price · Currency is HKD 2.940
0.00 (0.00%)
Jun 17, 2026, 1:29 PM HKT
3D Medicines Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -177.53 | -182.66 | -524.7 | -1,024 | -1,434 |
Depreciation & Amortization | 15.06 | 25.15 | 25.36 | 21.5 | 12.51 |
Other Amortization | 0.1 | 0.1 | 0.1 | 0.1 | 0.08 |
Loss (Gain) From Sale of Assets | 0 | -0.01 | - | - | 0.96 |
Asset Writedown & Restructuring Costs | - | 4.07 | - | - | - |
Loss (Gain) From Sale of Investments | 4.17 | 1.14 | -8.22 | 658.18 | 954.69 |
Stock-Based Compensation | 24.81 | 32.67 | 298.96 | 141.69 | 164.66 |
Other Operating Activities | -15.82 | -45.61 | -46.91 | -68.55 | -36.01 |
Change in Accounts Receivable | 27.32 | -42.66 | 72.71 | -13.06 | -65.13 |
Change in Inventory | 0.55 | 0.55 | -3.42 | -1.18 | -0.01 |
Change in Accounts Payable | 38.05 | -20.77 | 56.02 | 12.14 | 1.33 |
Change in Unearned Revenue | - | -24.54 | 24.54 | - | - |
Change in Other Net Operating Assets | -75.98 | 41.98 | -38.86 | -5.24 | 23.94 |
Operating Cash Flow | -159.26 | -210.58 | -144.41 | -278.78 | -377.08 |
Capital Expenditures | -0.02 | -45.36 | -6.32 | -53.98 | -43.87 |
Sale of Property, Plant & Equipment | - | 0.03 | - | - | - |
Sale (Purchase) of Intangibles | - | - | - | - | -1.01 |
Investment in Securities | 70.57 | 52.46 | -187.68 | -194.2 | -49.58 |
Other Investing Activities | -92.01 | 10.82 | 6.43 | 6.07 | -4.41 |
Investing Cash Flow | -21.47 | 17.95 | -187.58 | -242.11 | -98.87 |
Long-Term Debt Issued | 121.46 | 261.35 | 242.6 | 149.04 | - |
Total Debt Issued | 121.46 | 261.35 | 242.6 | 149.04 | - |
Long-Term Debt Repaid | -216.44 | -292.52 | -170.22 | -31.53 | -9.25 |
Total Debt Repaid | -216.44 | -292.52 | -170.22 | -31.53 | -9.25 |
Net Debt Issued (Repaid) | -94.98 | -31.17 | 72.38 | 117.51 | -9.25 |
Issuance of Common Stock | 1.24 | - | 219.22 | 315.13 | 6.02 |
Repurchase of Common Stock | - | -0.27 | -0.04 | -0.04 | -32.73 |
Other Financing Activities | 1.8 | -2.49 | 12.95 | -24.19 | -534.21 |
Financing Cash Flow | -91.94 | -33.92 | 304.51 | 408.41 | 840.08 |
Foreign Exchange Rate Adjustments | -1.42 | 4.39 | -2.79 | 34.91 | -4.09 |
Net Cash Flow | -274.08 | -222.15 | -30.27 | -77.57 | 360.05 |
Free Cash Flow | -159.28 | -255.94 | -150.74 | -332.76 | -420.95 |
Free Cash Flow Margin | -44.73% | -57.43% | -23.74% | -58.65% | -698.56% |
Free Cash Flow Per Share | -0.65 | -1.04 | -0.66 | -7.32 | -10.78 |
Cash Interest Paid | - | - | - | 1.91 | 1.53 |
Cash Income Tax Paid | 0.08 | - | - | - | - |
Levered Free Cash Flow | -101.16 | -186.63 | 119.74 | -120.65 | -192.3 |
Unlevered Free Cash Flow | -97.9 | -180.69 | 124.6 | -118.7 | -191.35 |
Change in Working Capital | -10.06 | -45.43 | 110.99 | -7.35 | -39.88 |